Trial ID or NCT#

NCT01730170

Status

NOT RECRUITING

Purpose

Epilepsy is one of the most common neurological disorders affecting women of childbearing age. Poor pregnancy outcomes are increased in these women and their children. The proposed studies will increase our knowledge on multiple levels to improve care and reduce adverse outcomes in these mothers and children. An overall goal of this study is to establish the relationship between antiepileptic drug exposure and outcomes in the mother and child as well as describe and explain the variability in antiepileptic drug exposure and response.

Official Title

Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs

Eligibility Criteria

Ages Eligible for Study: 14 Years to 45 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: Yes

Investigator(s)

Kimford J. Meador, MD
Epilepsy specialist, Neurophysiologist
Professor of Neurology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM